Investors have the power to influence companies to take action for global health. Armed with the Foundation’s analysis and insights, investors can make informed decisions and steward investee companies towards both sustainability and prosperity. Besides providing tailored advice on access to medicine topics, we also generate opportunities for collaborative action.
Signatory investors gain a whole host of benefits, including:
The Foundation is committed to providing its data and analysis free of charge to all stakeholder groups, including investors.
Read our investor statement here.
Investor Engagement Manager
Investors are strongest when they pool their influence. By joining the Foundation's collaborative initiatives, investors can jointly steer investee companies to do better.
This unique opportunity allows investors to collectively drive pharma companies toward the achievement of the UN’s Sustainable Development Goal 3: to ensure healthy lives and promote well-being for all at all ages. This long-term investor-led engagement uses the Access to Medicine Index to drive and track pharmaceutical company progress and impact on increased access to medicine in LMICs. To date, over 145 investors managing assets of more than USD 22 trillion have committed to use our data and insights. Read our investor statement here.
Launched in 2020 by the Access to Medicine Foundation, the FAIRR initiative, the Principles for Responsible Investment and the UK Government’s Department of Health and Social Care, this initiative focuses on the role of capital markets in tackling the global threat of rising drug-resistant infections.
Ahead of the UN General Assembly’s second-ever High-Level Meeting on AMR in September, the IAAMR launched an Investor Statement calling on global leaders and policymakers to combat AMR. It includes seven critical requests, spotlighting solutions to the AMR crisis. The Statement seeks to galvanise investor efforts to address global AMR and is open for signing until 31 December 2024. So far, 80 investors managing USD 13 trillion in assets have signed the Statement. If you would like to become a Statement signatory, please reach out to the Foundation’s Investor Engagement Manager, Suzi van Es at svanes@accesstomedicinefoundation.org.
